Abstract
Scheel (this issue) shows that the effectiveness and mechanism of action of dialectical behavior therapy (DBT) for borderline personality disordered (BPD) patients are not as conclusive or well understood as many have come to believe. Scheel's conclusions are well balanced, and she does point out the strengths of the DBT approach. Most important, Scheel provides clear guidance about the types of studies that need to be conducted to fully establish DBT as the treatment of choice for BPD. Future studies are going to have to forgo the TAU control and use well-established alternative treatments. Controls for dosage of the treatments, therapists, supervision, and therapeutic allegiance will have to be implemented. In addition, a broader, more representative outcome battery will need to be used. An important virtue of Scheel's review is that it exemplifies the virtues of the clinical science approach to evaluating psychosocial treatment through falsification of hypotheses.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
